Allergy pill could calm inflamed guts, study suggests
NCT ID NCT07333716
Summary
This study is testing if adding a common allergy medicine, desloratadine, to standard ulcerative colitis treatment helps patients feel better. It will involve 44 adults with mild-to-moderate disease who are already taking mesalamine. Researchers want to see if the drug reduces gut inflammation and improves symptoms by blocking certain immune signals.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Menofia university Hospitals
RECRUITINGShibīn al Kawm, Menofia, 32511, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.